Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 5, 2014, Pages e991-e1002

  Palange, Anna L ^a,b   Di Mascolo, Daniele ^a,b   Carallo, Claudio ^b   Gnasso, Agostino ^b   Decuzzi, Paolo ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Cancer prevention; Cell adhesion; Metastasis; Nanoparticles; Vascular inflammation

Indexed keywords

CELL ADHESION; CELL CULTURE; DEPOSITION; DISEASES; ENZYME INHIBITION; NANOPARTICLES; PATHOLOGY; TUMORS;

BREAST CANCER CELLS; CANCER PREVENTION; CIRCULATING TUMOR CELLS; DISTANT METASTASIS; LIPID NANOPARTICLES; METASTASIS; POLYMER NANOPARTICLES; VASCULAR INFLAMMATION;

ENDOTHELIAL CELLS;

CURCUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LIPID POLYMER NANOPARTICLE; MACROGOL; NANOPARTICLE; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CELL ADHESION; CELL VIABILITY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; IMMUNOCHEMISTRY; IN VITRO STUDY; METASTASIS POTENTIAL; NANOENCAPSULATION; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULITIS; CHEMISTRY; DRUG EFFECTS; FEMALE; METABOLISM; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CURCUMIN; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPIDS; NANOPARTICLES; POLYMERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903538176     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.02.004     Document Type: Article

References (50)

1. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
2. Kang Y., Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer cell 2013, 23:573-581.
3. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-458.
4. Mego M., Mani S.A., Cristofanilli M. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat Rev Clin Oncol 2010, 7:693-701.
5. Yu M., Bardia A., Wittner B.S., Stott S.L., Smas M.E., Ting D.T., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
6. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
7. Ghazani AA, McDermott S, Pectasides M, Sebas M, Mino-Kenudson M, Lee H, et al. Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and miniaturized micro-NMR system. Nanomedicine: Nanotechnology, Biology and Medicine 2013; (In press).
8. Grobmyer S.R., Zhou G., Gutwein L.G., Iwakuma N., Sharma P., Hochwald S.N. Nanoparticle delivery for metastatic breast cancer. Maturitas 2012, 73:19-26.
9. Miles F.L., Pruitt F.L., van Golen K.L., Cooper C.R. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008, 25:305-324.
10. Yang L., Froio R.M., Sciuto T.E., Dvorak A.M., Alon R., Luscinskas F.W. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow. Blood 2005, 106:584-592.
11. Kawai Y., Kaidoh M., Ohhashi T. MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells. Am J Physiol Cell Physiol 2008, 295:C1123-C1132.
12. Liang S., Dong C. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions. Am J Physiol Cell Physiol 2008, 295:C701-C707.
13. Läubli H., Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol 2010, 20:169-177. Elsevier.
14. Tremblay P.-L., Huot J., Auger F.A. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res 2008, 68:5167-5176.
15. Borsig L, Wolf M, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis-tracing the accessory. Oncogene 2013; (In press).
16. McDonald B., Spicer J., Giannais B., Fallavollita L., Brodt P., Ferri L.E. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 2009, 125:1298-1305.
17. Taranova A.G., Maldonado D., Vachon C.M., Jacobsen E.A., Abdala-Valencia H., McGarry M.P., et al. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res 2008, 68:8582-8589.
18. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003, 348:1625-1638.
19. Iyengar N.M., Morris P.G., Hudis C.A., Dannenberg A.J. Obesity, inflammation, and breast cancer. Obesity, Inflammation and Cancer 2013, 181-217. Springer.
20. Sawabata N., Okumura M., Utsumi T., Inoue M., Shiono H., Minami M., et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007, 55:189-192.
21. Cools-Lartigue J., Spicer J., McDonald B., Gowing S., Chow S., Giannias B., et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2013, 123:3446.
22. Shehzad A., Rehman G., Lee Y.S. Curcumin in inflammatory diseases. BioFactors 2013, 39:69-77.
23. Kunnumakkara A.B., Anand P., Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008, 269:199-225.
24. Zhou H., Beevers C.S., Huang S. Targets of curcumin. Current Drug Targets 2011, 12:332.
25. Chen H.-W., Lee J.-Y., Huang J.-Y., Wang C.-C., Chen W.-J., Su S.-F., et al. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008, 68:7428-7438.
26. Sharma R.A., McLelland H.R., Hill K.A., Ireson C.R., Euden S.A., Manson M.M., et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001, 7:1894-1900.
27. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008, 14:4491-4499.
28. Ireson C., Orr S., Jones D.J., Verschoyle R., Lim C.-K., Luo J.-L., et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001, 61:1058-1064.
29. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
30. Ryu J.H., Koo H., Sun I.-C., Yuk S.H., Choi K., Kim K., et al. Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy. Adv Drug Deliv Rev 2012, 64:1447-1458.
31. Koo O.M., Rubinstein I., Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005, 1:193-212.
32. Hu C.-M.J., Zhang L., Aryal S., Cheung C., Fang R.H., Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci 2011, 108:10980-10985.
33. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
34. Yallapu M.M., Ebeling M.C., Khan S., Sundram V., Chauhan N., Gupta B.K., et al. Novel curcumin loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther 2013, 12:1471-1480.
35. Bisht S., Mizuma M., Feldmann G., Ottenhof N.A., Hong S.-M., Pramanik D., et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 2010, 9:2255-2264.
36. Li L., Ahmed B., Mehta K., Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007, 6:1276-1282.
37. Lin Y.-L., Liu Y.-K., Tsai N.-M., Hsieh J.-H., Chen C.-H., Lin C.-M., et al. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomedicine 2012, 8:318-327.
38. Aryal S., Key J., Stigliano C., Ananta J.S., Zhong M., Decuzzi P. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging. Biomaterials 2013, 34:7725-7732.
39. Zhang L., Chan J.M., Gu F.X., Rhee J.-W., Wang A.Z., Radovic-Moreno A.F., et al. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008, 2:1696-1702.
40. Lawrence M.B., Springer T.A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991, 65:859-873.
41. Adriani G., de Tullio M.D., Ferrari M., Hussain F., Pascazio G., Liu X., et al. The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials 2012, 33:5504-5513.
42. Regimbald L.H., Pilarski L.M., Longenecker B.M., Reddish M.A., Zimmermann G., Hugh J.C. The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 1996, 56:4244-4249.
43. Ciborowski P., Finn O.J. Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis. Clin Exp Metastasis 2002, 19:339-345.
44. Shen Q., Rahn J.J., Zhang J., Gunasekera N., Sun X., Shaw A.R., et al. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1. Mol Cancer Res 2008, 6:555-567.
45. Kufe D.W. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009, 9:874-885.
46. Geng Y, Yeh K, Takatani T, King MR. Three to tango: MUC1 as a ligand for both E-selectin and ICAM-1 in the breast cancer metastatic cascade. Frontiers in, oncology 2012;2.
47. Dianzani C., Brucato L., Gallicchio M., Rosa A., Collino M., Fantozzi R. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br J Pharmacol 2008, 153:1153-1161.
48. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4:71-78.
49. Qian B.-Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
50. Aryal S., Hu C.-M.J., Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm 2011, 8:1401-1407.